Global Prosthetic Heart Valve Market Size Study & Forecast, by Valve (Transcatheter Heart Valves, Bioprosthetic (Tissue) Valves, Mechanical Valves), Material (Biological Tissue, Pyrolytic Carbon), End-use and Regional Forecasts 2025-2035

Description

The Global Prosthetic Heart Valve Market is valued at approximately USD 9.64 billion in 2024 and is anticipated to grow with a strong CAGR of 8.70% over the forecast period of 2025-2035. Prosthetic or artificial heart valves, designed to replace malfunctioning native heart valves, have become pivotal in the management of valvular heart disease, one of the leading cardiovascular disorders worldwide. These life-saving devices are engineered either from biological tissue or mechanical materials and are deployed through surgical or transcatheter procedures. The market is witnessing a remarkable upswing as the burden of cardiovascular diseases accelerates globally, fueled by rising life expectancy, sedentary lifestyles, and a growing prevalence of risk factors such as hypertension, obesity, and diabetes. Moreover, continuous advancements in minimally invasive valve replacement techniques and the surge in adoption of transcatheter heart valve procedures have reshaped the therapeutic landscape, making them accessible to high-risk and elderly patient populations.

The expansion of the prosthetic heart valve market is further reinforced by the dramatic improvements in device durability, biocompatibility, and clinical outcomes. Transcatheter Aortic Valve Replacement (TAVR) has transformed into a mainstream therapeutic option and is witnessing exponential adoption due to its lower recovery times and reduced surgical risks compared to traditional open-heart surgery. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths each year, with valvular heart disease representing a significant portion of these cases. The increasing number of clinical trials, government-backed health initiatives, and a swelling wave of investments in structural heart disease therapies are creating lucrative opportunities for market growth. Nonetheless, challenges such as the high cost of valve implants, the need for anticoagulation therapy in mechanical valves, and the disparity in access to advanced healthcare technologies in emerging economies could hinder the pace of adoption.

Regionally, North America held the lion's share of the global prosthetic heart valve market in 2024, attributed to its robust healthcare infrastructure, strong penetration of advanced cardiovascular therapies, and supportive reimbursement frameworks. The United States, in particular, continues to lead in transcatheter valve adoption owing to favorable FDA approvals and broad physician acceptance. Europe follows closely, supported by high awareness levels, government initiatives, and increasing geriatric populations across countries like Germany, France, and the UK. Asia Pacific, however, is anticipated to witness the fastest growth throughout the forecast horizon. Rising healthcare expenditure, rapid urbanization, and surging cardiovascular disease burden in nations such as China and India are key accelerators. Moreover, collaborations between global medtech giants and regional healthcare providers are paving the way for expanded access to next-generation valve therapies. Meanwhile, Latin America and the Middle East & Africa, although growing at a comparatively moderate rate, are showing steady adoption patterns driven by improving healthcare infrastructure and gradual regulatory alignment with global standards.

Major market players included in this report are:

Medtronic plc
Abbott Laboratories
Edwards Lifesciences Corporation
Boston Scientific Corporation
CryoLife, Inc.
LivaNova PLC
JenaValve Technology, Inc.
Colibri Heart Valve LLC
Meril Life Sciences Pvt. Ltd.
Micro Interventional Devices, Inc.
TTK Healthcare Limited
Lepu Medical Technology Co., Ltd.
Artivion, Inc.
Corcym S.r.l.
Braile Biomedica

Global Prosthetic Heart Valve Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Valve:

Transcatheter Heart Valves
Bioprosthetic (Tissue) Valves
Mechanical Valves

By Material:

Biological Tissue
Pyrolytic Carbon

By End-use:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Prosthetic Heart Valve Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Prosthetic Heart Valve Market Forces Analysis

3.1. Market Forces Shaping The Global Prosthetic Heart Valve Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of valvular heart disease and aging demographics
- 3.2.2. Accelerated adoption of minimally invasive TAVR and expanding clinical indications
3.3. Restraints
- 3.3.1. High device and procedure costs with reimbursement variability
- 3.3.2. Anticoagulation/durability trade-offs and access gaps in emerging markets
3.4. Opportunities
- 3.4.1. Next-generation materials (anti-calcification, enhanced biocompatibility) and device innovations
- 3.4.2. High-growth prospects in Asia Pacific and transcatheter therapies for mitral/tricuspid valves

Chapter 4. Global Prosthetic Heart Valve Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Prosthetic Heart Valve Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Prosthetic Heart Valve Market Performance - Potential Analysis (2025)
5.3. Transcatheter Heart Valves
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Bioprosthetic (Tissue) Valves
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Mechanical Valves
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Prosthetic Heart Valve Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Prosthetic Heart Valve Market Performance - Potential Analysis (2025)
6.3. Hospitals
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Specialty Clinics
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Ambulatory Surgical Centers
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Prosthetic Heart Valve Market Size & Forecasts by Region 2025-2035

7.1. Prosthetic Heart Valve Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Prosthetic Heart Valve Market
- 7.3.1. U.S. Prosthetic Heart Valve Market
  - 7.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Prosthetic Heart Valve Market
  - 7.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Prosthetic Heart Valve Market
- 7.4.1. UK Prosthetic Heart Valve Market
  - 7.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Prosthetic Heart Valve Market
  - 7.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Prosthetic Heart Valve Market
  - 7.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Prosthetic Heart Valve Market
  - 7.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Prosthetic Heart Valve Market
  - 7.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Prosthetic Heart Valve Market
  - 7.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Prosthetic Heart Valve Market
- 7.5.1. China Prosthetic Heart Valve Market
  - 7.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Prosthetic Heart Valve Market
  - 7.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Prosthetic Heart Valve Market
  - 7.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Prosthetic Heart Valve Market
  - 7.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Prosthetic Heart Valve Market
  - 7.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Prosthetic Heart Valve Market
  - 7.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Prosthetic Heart Valve Market
- 7.6.1. Brazil Prosthetic Heart Valve Market
  - 7.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Prosthetic Heart Valve Market
  - 7.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Prosthetic Heart Valve Market
- 7.7.1. UAE Prosthetic Heart Valve Market
  - 7.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Prosthetic Heart Valve Market
  - 7.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Prosthetic Heart Valve Market
  - 7.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Edwards Lifesciences Corporation
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Medtronic plc
8.4. Abbott Laboratories
8.5. Boston Scientific Corporation
8.6. LivaNova PLC
8.7. CryoLife, Inc.
8.8. Artivion, Inc.
8.9. Corcym S.r.l.
8.10. Meril Life Sciences Pvt. Ltd.
8.11. Colibri Heart Valve LLC
8.12. JenaValve Technology, Inc.
8.13. Braile Biomedica
8.14. Micro Interventional Devices, Inc.
8.15. TTK Healthcare Limited
8.16. Lepu Medical Technology Co., Ltd.